Key Takeaway
After 1 year on GLP-1 medications, most patients lose 20 to 60 pounds depending on the medication. Here is a thorough comparative analysis with clinical data.
One year on a GLP-1 medication is the gold standard benchmark for evaluating treatment success. Patients researching GLP-1 results after 1 year will find that these medications deliver substantial, clinically meaningful weight loss across the entire class, with totals ranging from 20 to 60 pounds depending on the specific medication . The one-year mark also reveals the full scope of metabolic health improvements these medications produce.
One-Year Comparison: All GLP-1 Medications
| Medication | 1-Year Weight Loss | Body Weight % Lost | Key Trial Reference |
|---|---|---|---|
| Tirzepatide 15 mg (Zepbound) | 45 to 60 lbs | 20% to 24% | SURMOUNT-1[1] |
| Tirzepatide 10 mg (Mounjaro) | 35 to 50 lbs | 16% to 20% | SURMOUNT-1 |
| Semaglutide 2.4 mg (Wegovy) | 28 to 45 lbs | 12% to 17% | STEP 1[2] |
| Semaglutide 2.0 mg (Ozempic) | 22 to 32 lbs | 9% to 13% | SUSTAIN series |
| Compounded semaglutide | 25 to 40 lbs | 10% to 16% | Equivalent to brand |
| Liraglutide 3.0 mg (Saxenda) | 18 to 28 lbs | 7% to 11% | SCALE trials |
The hierarchy is clear: tirzepatide leads, followed by high-dose semaglutide, standard semaglutide, and then liraglutide. Each medication represents a meaningful improvement over lifestyle changes alone, which typically produce 5% to 10% weight loss .
thorough Health Impact at One Year
The one-year data across all GLP-1 medications shows consistent improvements in cardiometabolic health :
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
| Health Marker | Typical Improvement at 1 Year |
|---|---|
| Systolic blood pressure | 8 to 20 mmHg decrease |
| A1C (diabetic patients) | 1.5% to 3.5% decrease |
| Triglycerides | 20% to 50% decrease |
| LDL cholesterol | 5% to 20% decrease |
| CRP (inflammation) | 30% to 65% decrease |
| Liver enzymes (ALT) | 25% to 55% decrease |
| Fasting insulin | 25% to 55% decrease |
| Cardiovascular events (SELECT) | 20% reduction |
These improvements collectively produce a substantial reduction in the risk of heart disease, stroke, kidney disease, liver disease, certain cancers, and premature death. The health benefits of one year on a GLP-1 medication go far beyond cosmetic weight loss .
The Big Picture: What One Year Means
Looking back on a full year of GLP-1 therapy, here is what most patients have experienced:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Months 1 to 4: Dose titration and early adaptation. Foundation building. 30% to 40% of total weight loss occurs here.
- Months 5 to 8: Peak weight loss velocity. 35% to 45% of total weight loss occurs during this phase.
- Months 9 to 12: Deceleration and stabilization. The remaining 15% to 25% of total weight loss occurs gradually.
The most important insight: patience during the early months pays off dramatically by the one-year mark. Patients who stay committed through the slow titration phase are rewarded with some of the most impressive weight loss results achievable without surgery.
The Maintenance Challenge
The central challenge at one year is maintaining the weight loss . Current evidence shows:
- Patients who continue treatment maintain their weight loss
- Patients who stop typically regain two-thirds of lost weight within 12 months
- Lifestyle changes alone are insufficient for most patients to maintain GLP-1 level weight loss
- Lower maintenance doses may sustain results at reduced cost
This reality has led most obesity medicine specialists to view GLP-1 therapy as a long-term or chronic treatment, similar to medications for blood pressure or cholesterol .
Long-Term Treatment Planning
- Annual health assessment. thorough lab work, body composition, cardiovascular fitness, and nutritional status evaluation.
- Dose improvement. Many patients can maintain at a lower dose, improving affordability.
- Cost-effective options. Compounded semaglutide and tirzepatide through FormBlends offer affordable long-term treatment FormBlends pricing.
- Lifestyle sustainability. Ensure your exercise, nutrition, and sleep habits can be maintained independently of the medication.
- Ongoing provider support. Regular check-ins help identify and address any issues early FormBlends telehealth consultation.
Medical References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. [PubMed | ClinicalTrials.gov | DOI]
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
Frequently Asked Questions
Which GLP-1 medication produces the best one-year results?
Tirzepatide at 15 mg produces the greatest average weight loss (about 22.5% of body weight[1]), followed by semaglutide 2.4 mg (about 15%). The best choice depends on individual response, health needs, insurance coverage, and cost considerations GLP-1 medication comparison.
Is one year enough time on a GLP-1?
One year is the minimum recommended treatment duration for most patients. Many benefit from continued therapy. Discuss your individual timeline with your provider .
What if I haven't lost as much weight as the clinical trials suggest?
Clinical trial averages include both high and low responders. Individual results depend on many factors. Even a 5% to 10% weight loss produces significant health benefits. Your provider can help improve your results or consider switching medications.
How do GLP-1 results at one year compare to bariatric surgery?
Bariatric surgery produces 25% to 35% weight loss on average. Tirzepatide 15 mg reaches about 22.5%, and semaglutide 2.4 mg reaches about 15%. Surgery produces more weight loss but carries surgical risks and is irreversible .
Can I take GLP-1 medications for more than one year?
Yes. Clinical trials have studied these medications for 68 to 72 weeks, and real-world use extends well beyond that. Long-term safety data is reassuring, and ongoing treatment is often recommended for weight maintenance .